BIOREM Inc. announced $10.6 million of new orders for air emission abatement projects in North America. These orders bring the company's current order backlog to a record $50.4 million, its highest point since the company was founded in 1990. The new products at the heart of these orders were introduced to a carefully-selected trial market segment.

This positive initial customer response bodes well for markets outside the test area, and the company's sales network will begin marketing them to other domestic and global customers in the coming months.